The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Open accessAbstract
The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Seventeen (35%) of these subjects progressed from NGT to IGT and then to diabetes during follow up.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“During follow up, insulin secretion declined progressively by 78% while insulin sensitivity decreased by only 14%.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [10]
In the citing paper
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [20]
In the citing paper
“IGT and T2DM ensue when beta cell function fails to compensate.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
In the citing paper
“Insulin resistance precedes the development of hyperglycemia and T2DM and results in compensatory hyperinsulinemia.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Body composition from fluid spaces and density: analysis of methods. 1961.
Siri, W. E. (1994) · PubMed · Cited by 2,556
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 5×
“It is well known that there is a hyperbolic relationship between early insulin secretion and insulin action in individuals with NGT, meaning that, cross-sectionally, insulin secretion increases with decreasing insulin action and vice versa (51, 52).”
BackgroundMethodInfluentialTechniques for Measuring Body Composition
National Research Council (1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,620
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- 1998, Diabetes Care, 21(Suppl. 1), S5
- DeFronzo, 1997, Diabetes Reviews, 5, 177
- Abbott, 1990, Am J Physiol, 258, E347
- Bogardus, 1984, J Clin Invest, 78, 1568
- Schwartz, 1995, J Clin Endocrinol Metab, 80, 1571
- Luzi, 1989, Am J Physiol, 257, E241
Cited by
Sorted by citations
Items 201–300 of 1,002
Sirtuins and Insulin Resistance
Zhou, S., Tang, X., & Chen, H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00748 · Cited by 155
The Genetic Basis of Type 2 Diabetes.
Das, S. K., & Elbein, S. C. (2006) · PubMed · doi:10.1901/jaba.2006.2-100 · Cited by 153
The place of sulfonylureas in the therapy for type 2 diabetes mellitus
Prato, S. D., & Pulizzi, N. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.003 · Cited by 154
Saponins from Sea Cucumber and Their Biological Activities
Zhao, Y., Xue, C., Zhang, T., & Wang, Y.-M. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01770 · Cited by 153
Hoppa, M. B., Collins, S., Ramracheya, R., Hodson, L., Amisten, S., Zhang, Q., Johnson, P., Ashcroft, F. M., & Rorsman, P. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.011 · Cited by 152
β-Cell function in type 2 diabetes
Ferrannini, E., & Mari, A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.012 · Cited by 153
Lee, J., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094843 · Cited by 151
Del Prato, S., Felton, A.-M., Munro, N., Nesto, R., Zimmet, P., & Zinman, B. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00674.x · Cited by 150
Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications
Retnakaran, R. R., Hanley, A. J., Raif, N., Hirning, C. R., Connelly, P. W., Sermer, M., Kahn, S. E., & Zinman, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1710-x · Cited by 148
Animal models of type 2 diabetes with reduced pancreatic β-cell mass
Masiello, P. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.09.007 · Cited by 148
Chiasson, J. L., & RABASA-LHORET, R. P. R. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s34 · Cited by 148
Diabetic cardiomyopathy: mechanisms and therapeutic targets
Battiprolu, P. K., Gillette, T. G., Wang, Z. V., Lavandero, S., & Hill, J. A. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.08.001 · Cited by 144
Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion
Wang, H., Chu, W. S., Lu, T., Hasstedt, S. J., Kern, P. A., & Elbein, S. C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00231.2003 · Cited by 143
Xiao, Y., Zheng, L., Zou, X., Wang, J., Zhong, J., & Zhong, T. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1625677 · Cited by 142
Bergman, M. (2012) · Endocrine · doi:10.1007/s12020-012-9830-9 · Cited by 142
Porte, D. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200105/06)17:3 · Cited by 143
The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes
Abdul‐Ghani, M. A., Lyssenko, V., Tuomi, T., DeFronzo, R. A., & Groop, L. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1084 · Cited by 139
Bond, G. E., Burr, R. L., Wolf, F. M., & Feldt, K. S. (2010) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721710366758 · Cited by 138
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
Crandall, J. P., Mather, K., Rajpathak, S. N., Goldberg, R. B., Watson, K., Foo, S., Ratner, R., Barrett-Connor, E., & Temprosa, M. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000438 · Cited by 137
The Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes
Jia, J. ‐., Zhang, X., Ge, C. ‐., & Jois, M. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00569.x · Cited by 137
Jayamani, J., & Shanmugam, G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.111 · Cited by 135
Sleep architecture and glucose and insulin homeostasis in obese adolescents
Koren, D., Levitt Katz, L. E., Brar, P. C., Gallagher, P. R., Berkowitz, R. I., & Brooks, L. J. (2011) · Diabetes Care · doi:10.2337/dc11-1093 · Cited by 134
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
Liu, J., Yu, P., Qian, W., Li, Y., Zhao, J., Huan, F., Wang, J., & Xiao, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064143 · Cited by 132
The GK rat beta-cell: A prototype for the diseased human beta-cell in type 2 diabetes?
Portha, B., Lacraz, G., Kergoat, M., Homo-Delarche, F., Giroix, M.-H., Bailbé, D., Gangnerau, M.-N., Dolz, M., Tourrel‐Cuzin, C., & Movassat, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.013 · Cited by 131
Importance of Early Insulin Secretion
Hollander, P. A., Schwartz, S. L., Gatlin, M. R., Haas, S. J., Zheng, H., Foley, J. E., & Dunning, B. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.983 · Cited by 131
Effect of maternal feed restriction during pregnancy on glucose tolerance in the adult guinea pig
Kind, K. L., Clifton, P. M., Grant, P. A., Owens, P. C., Sohlström, A., Roberts, C. T., Robinson, J. S., & Owens, J. A. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00587.2001 · Cited by 131
Pancreatic beta-cell loss and preservation in type 2 diabetes
Buchanan, T. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80241-2 · Cited by 132
Effect of donor age on function of isolated human islets
Ihm, S.-H., Matsumoto, I., Sawada, T., Nakano, M., Zhang, H. J., Ansite, J. D., Sutherland, D. E. R., & Hering, B. J. (2006) · Diabetes · doi:10.2337/db05-1333 · Cited by 130
INSULIN THERAPY IN TYPE 2 DIABETES
Mudaliar, S. R., & Edelman, S. V. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70222-x · Cited by 130
Xie, X., Wu, C., Hao, Y., Wang, T., Yang, Y., Cai, P., Zhang, Y., Huang, J., Deng, K., Yan, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1301093 · Cited by 129
Looker, H. C., Krakoff, J. A., Funahashi, T., Matsuzawa, Y., Tanaka, S., Nelson, R. G., Knowler, W. C., Lindsay, R. S., & Hanson, R. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031916 · Cited by 129
Helicobacter pyloriinfection and diabetes: Is it a myth or fact
He, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4607 · Cited by 128
Defects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus
Tripathy, D., & Chávez, A. O. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0115-5 · Cited by 128
Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M. P. (2006) · Diabetes Care · doi:10.2337/dc05-1711 · Cited by 128
Narrative Review: A Rational Approach to Starting Insulin Therapy
Mooradian, A. D., Bernbaum, M., & Albert, S. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-2-200607180-00010 · Cited by 127
Blackstone, R. P., Bunt, J. C., Cortés, M. C., & Sugerman, H. J. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.05.005 · Cited by 126
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
Bigdelou, B., Sepand, M. R., Najafikhoshnoo, S., Negrete, J. A. T., Sharaf, M., Ho, J. Q., Sullivan, I., Chauhan, P. S., Etter, M. M., Shekarian, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890517 · Cited by 126
Costes, S., Huang, C.-J., Gurlo, T., Daval, M., Matveyenko, A. V., Rizza, R. A., Butler, A. E., & Butler, P. C. (2010) · Diabetes · doi:10.2337/db10-0522 · Cited by 126
Cali, A. M. G., Man, C. D., Cobelli, C., Dziura, J., Seyal, A., Shaw, M., Allen, K., Chen, S., & Caprio, S. (2009) · Diabetes Care · doi:10.2337/dc08-1274 · Cited by 125
Hays, N. P., Galassetti, P. R., & Coker, R. H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.003 · Cited by 125
Hanley, A. J., Wagenknecht, L. E., D’Agostino, R. B., Zinman, B., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2740 · Cited by 125
Gu, L., Ding, X., Wang, Y., Gu, M., Zhang, J., Yan, S., Li, N., Song, Z., Yin, J., Lu, L., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31781 · Cited by 124
Adewole, S., Caxton-Martins, E. A., & Ojewole, J. (2007) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v4i1.31196 · Cited by 124
Bhattacharya, S., Oksbjerg, N., Young, J. F., & Jeppesen, P. B. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12236 · Cited by 123
Sites, C. K., L’Hommedieu, G. D., Toth, M. J., Brochu, M., Cooper, B. C., & Fairhurst, P. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1479 · Cited by 122
Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives
Virally, M., Blickle, J., Girard, J. R., Halimi, S., Simon, D., & Guillausseau, P.-J. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.07.001 · Cited by 122
Calcium Signaling in ß-cell Physiology and Pathology: A Revisit
Klec, C., Ziomek, G., Pichler, M., Malli, R., & Graier, W. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246110 · Cited by 121
Greenbaum, C. J., Prigeon, R. L., & D’Alessio, D. A. (2002) · Diabetes · doi:10.2337/diabetes.51.4.951 · Cited by 121
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs583 · Cited by 120
The RISC Investigators, Mari, A., Tura, A., Natali, A., Laville, M., Laakso, M., Gabriel, R., Beck-Nielsen, H., & Ferrannini, E. (2010) · Diabetologia · doi:10.1007/s00125-009-1647-6 · Cited by 120
Diabesity: therapeutic options
Colagiuri, S. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01182.x · Cited by 121
Khetan, A. K., & Rajagopalan, S. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.030 · Cited by 119
Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes
Son, J., & Accili, D. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01043-8 · Cited by 122
Weyer, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.779 · Cited by 119
Self-citationDietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome
Laaksonen, D. E., Toppinen, L., Juntunen, K. S., Autio, K., Liukkonen, K. H., Poutanen, K. S., NISKANEN, L. K., & Mykkänen, H. M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1218 · Cited by 119
Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review
Inaishi, J., & Saisho, Y. (2020) · Nutrients · doi:10.3390/nu12123846 · Cited by 119
Novoa, F. J., Boronat, M., Saavedra, P., Díaz-Cremades, J., Varillas, V. F., Roche, F. L., Alberiche, M., & Carrillo, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2388 · Cited by 118
Zhao, H., Lai, F. M., Tong, P. C. Y., Zhong, D., Yang, D., Tomlinson, B., & Chan, J. C. N. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2759 · Cited by 117
Vaishali, R., Sasikala, R., Ramasubbareddy, S., Remya, S., & Nalluri, S. (2017) · International Conference on Computing Networking and Informatics (ICCNI) · doi:10.1109/iccni.2017.8123815 · Cited by 116
Stümvoll, M., Tataranni, P. A., Stefan, N., de Courten, B. V., & Bogardus, C. (2003) · Diabetes · doi:10.2337/diabetes.52.4.903 · Cited by 116
Self-citationOsei, K., Rhinesmith, S., Gaillard, T. R., & Schuster, D. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1439 · Cited by 116
Type 2 Diabetes Mellitus in Youth: The Complete Picture to Date
Gungor, N., Hannon, T. S., Libman, I. M., Bacha, F. F., & Arslanian, S. A. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.07.009 · Cited by 116
Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
Davidson, M., Mattison, D. R., Azoulay, L., & Krewski, D. R. (2017) · Critical Reviews in Toxicology · doi:10.1080/10408444.2017.1351420 · Cited by 117
Hanley, A. J., Wagenknecht, L. E., Norris, J. M., Bryer‐Ash, M., Chen, Y. I., Anderson, A., Bergman, R. N., & Haffner, S. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1464-y · Cited by 117
Effects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114
Improved β-cell function after standardized weight reduction in severely obese subjects
Guldstrand, M., Åhrén, B., & Adamson, U. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00325.2002 · Cited by 114
Matsuda, T., Kido, Y., Asahara, S., Kaisho, T., Tanaka, T., Hashimoto, N., Shigeyama, Y., Takeda, A., Inoue, T., Shibutani, Y., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39721 · Cited by 113
Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A
Delong, T., Baker, R. L., He, J., Barbour, G., Bradley, B., & HASKINS, K. M. (2012) · Diabetes · doi:10.2337/db12-0112 · Cited by 113
Weight Effect of Current and Experimental Drugs for Diabetes Mellitus
Purnell, J. Q., & Weyer, C. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302010-00004 · Cited by 113
Self-citationHorton, E. S. (2009) · Obesity · doi:10.1038/oby.2009.388 · Cited by 111
Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors
Pratley, R. E., & Gilbert, M. P. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.73 · Cited by 112
Self-citationSrinivasan, S. R., Frontini, M., & Berenson, G. S. (2003) · Metabolism · doi:10.1053/meta.2003.50065 · Cited by 112
Yang, X., Pratley, R. E., Tokraks, S., Bogardus, C., & Permana, P. A. (2002) · Diabetologia · doi:10.1007/s00125-002-0905-7 · Cited by 112
Self-citationWe Can Change the Natural History of Type 2 Diabetes
Phillips, L. S., Ratner, R. E., Buse, J. B., & Kahn, S. E. (2014) · Diabetes Care · doi:10.2337/dc14-0817 · Cited by 109
Using Drosophila to discover mechanisms underlying type 2 diabetes
Alfa, R. W., & Kim, S. K. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.023887 · Cited by 111
Banting Memorial Lecture 2012 Reversing the twin cycles of Type 2 diabetes
Taylor, R. (2012) · Diabetic Medicine · doi:10.1111/dme.12039 · Cited by 111
Characterization and Heritability of Obesity and Associated Risk Factors in Vervet Monkeys
Kavanagh, K., Fairbanks, L. A., Bailey, J. N., Jorgensen, M. J., Wilson, M. D., Zhang, L., Rudel, L. L., & Wagner, J. D. (2007) · Obesity · doi:10.1038/oby.2007.199 · Cited by 110
Obesidade e síndrome metabólica na infância e adolescência
de Oliveira, C. L., de Mello, M. T., Cintra, I. D. P., & Fisberg, M. (2004) · Revista de Nutrição · doi:10.1590/s1415-52732004000200010 · Cited by 110
Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes
Zhao, Y.-F., Feng, D. D., & Chen, C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.11.008 · Cited by 110
The Incretin Approach for Diabetes Treatment
Holst, J. J., & Ørskov, C. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s197 · Cited by 110
Prevention of Diabetes With Pioglitazone in ACT NOW
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Gastaldelli, A., Henry, R. R., Kitabchi, A. E., et al. (2013) · Diabetes · doi:10.2337/db13-0265 · Cited by 109
The Physiological Rationale for Oral Insulin Administration
Arbit, E. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/1520915041705929 · Cited by 109
Calcineurin Inhibition and New-Onset Diabetes Mellitus After Transplantation
Chakkera, H. A., & Mandarino, L. J. (2012) · Transplantation · doi:10.1097/tp.0b013e31826e592e · Cited by 109
New forms of insulin and insulin therapies for the treatment of type 2 diabetes
Cahn, A., Miccoli, R., Dardano, A., & Prato, S. D. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00097-2 · Cited by 108
Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
Leahy, J. L., Hirsch, I. B., PETERSON, K. A., & Schneider, D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0668 · Cited by 110
Cusi, K. J., Kashyap, S., Gastaldelli, A., Bajaj, M. S., & Cersósimo, E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00624.2006 · Cited by 109
Central role and mechanisms of β‐cell dysfunction and death in friedreich ataxia–associated diabetes
Cnop, M., Igoillo‐Esteve, M., Rai, M., Corroller, A. B., Serroukh, Y. I. M., Depondt, C., Musuaya, A., Marhfour, I., Ladrière, L., Lopez, X. M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23698 · Cited by 108
Nagaretani, H., Nakamura, T., Funahashi, T., Kotani, K., Miyanaga, M., Tokunaga, K., Takahashi, M., Nishizawa, H., Kishida, K., Kuriyama, H., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2127 · Cited by 108
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
DEEDWANIA, P. C., & Fonseca, V. A. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.05.018 · Cited by 107
Bloem, C. J., & Chang, A. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1734 · Cited by 107
Hagen, M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg338 · Cited by 107
Plasma Adiponectin and Endogenous Glucose Production in Humans
Stefan, N., Stümvoll, M., de Courten, B. V., Weyer, C., Funahashi, T., Matsuzawa, Y., Bogardus, C., & Tataranni, P. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3315 · Cited by 107
Self-citationPhenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice
Kim, J. H., Stewart, T. P., Soltani‐Bejnood, M., Wang, L., Fortuna, J. M., Mostafa, O. A., Moustaïd‐Moussa, N., Shoieb, A. M., McEntee, M. F., Wang, Y., et al. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06647 · Cited by 105
Poon, T., Nelson, P., Shen, L. Z., Mihm, M. J., Taylor, K., Fineman, M. S., & Kim, D. S. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.467 · Cited by 105
DeFronzo, R. A., Triplitt, C., Qu, Y., Lewis, M. S., Maggs, D., & Glass, L. C. (2010) · Diabetes Care · doi:10.2337/dc09-1521 · Cited by 104
Fritsche, A., Wagner, R. J., Heni, M., Kantartzis, K., Machann, J., Schick, F., Lehmann, R., Peter, A., Dannecker, C., Fritsche, L., et al. (2021) · Diabetes · doi:10.2337/db21-0526 · Cited by 104
When β‐cells fail: lessons from dedifferentiation
Accili, D., Talchai, S. C., Kim-Muller, J. Y., Cinti, F., Ishida, E., Ordelheide, A., Kuo, T., Fan, J., & Son, J. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12723 · Cited by 104
Metabolic syndrome risk factors in overweight, obese, and extremely obese brazilian adolescents
Rizzo, A. C. B., Goldberg, T. B. L., da Silva, C. C., Kurokawa, C. S., Nunes, H. R. D. C., & Corrente, J. E. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-19 · Cited by 103
Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance
Chang, A. M., Smith, M. J., Gałecki, A. T., Bloem, C. J., & Halter, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0913 · Cited by 103
Metadata
- Authors
- Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weyer, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 787-794
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408438
- OpenAlex
- W2077149049
- Cited by
- 1,940
- References
- 68
- Citations by year
- 2026: 24 · 2025: 53 · 2024: 53 · 2023: 74 · 2022: 63 · 2021: 80 · 2020: 64 · 2019: 64 · 2018: 61 · 2017: 72 · 2016: 88 · 2015: 81 · 2014: 91 · 2013: 85 · 2012: 83
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, impaired glucose tolerance, Pima Indians, insulin-stimulated glucose disposal, weight gain, diabetes prevention, pathogenesis
- MeSH terms
- Insulin Secretion, Adult, Anthropometry, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Obesity, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
